Pericytes in the macrovascular intima: possible physiological and pathogenetic impact.

The frequently observed de-endothelialization of venous coronary bypass grafts prepared using standard methods exposes subendothelial prothrombotic cells to blood components, thus endangering patients by inducing acute thromboembolic infarction or long-term proliferative stenosis. Our aim was to gain deeper histological and physiological insight into these relations. An intricate network of subendothelial cells, characterized by histological features specific for true pericytes, was detected even in healthy vessels and forms, coupled to the luminal endothelium, a second leaflet of the macrovascular intima. These cells, and particularly those in the venous intima, express enormous concentrations of tissue factor and can recruit additional amounts of up to the 25-fold concentration within 1 h during preincubation with serum (intimal pericytes of venous origin activate 30.71 +/- 4.07 pmol coagulation factor x.min(-1).10(-6) cells; n = 15). Moreover, decoupled from the endothelium, they proliferate rapidly (generation time, 15 +/- 2.1 h, n = 8). Central regions of atherosclerotic plaques, as well as of those of restenosed areas of coronary vein grafts, consist almost completely of these cells. In stark contrast with the prothrombogenicity of the intimal pericytes, intact luminal endothelium recruits high concentrations of thrombomodulin (CD 141) specifically within its intercellular junctions, activates Protein C rapidly (42 +/- 5.1 pmol/min.10(6) venous endothelial cells at thrombin saturation; n = 15), can thus actively prevent coagulatory processes, and never expresses histologically detectable and functionally active tissue factor. Given this strongly prothrombotic potential of the intimal pericytes and their overshooting growth behavior in endothelium-denuded vascular regions, they may play important roles in the development of atherosclerosis, thrombosis, and saphenous vein graft disease.

[1]  M. Uchiba [Activated protein C]. , 2011, Rinsho byori. The Japanese journal of clinical pathology.

[2]  S. Nees,et al.  Extensive deendothelialization and thrombogenicity in routinely prepared vein grafts for coronary bypass operations: facts and remedy. , 2009, International journal of clinical and experimental medicine.

[3]  P. Dore‐Duffy,et al.  Pericytes: pluripotent cells of the blood brain barrier. , 2008, Current pharmaceutical design.

[4]  B. Sacchetti,et al.  Pericytes of human skeletal muscle are myogenic precursors distinct from satellite cells , 2007, Nature Cell Biology.

[5]  M. Karasek,et al.  Inflammatory cytokines induce the transformation of human dermal microvascular endothelial cells into myofibroblasts: a potential role in skin fibrogenesis , 2007, Journal of cutaneous pathology.

[6]  Peter Libby,et al.  Atherosclerosis: disease biology affecting the coronary vasculature. , 2006, The American journal of cardiology.

[7]  J. Freyssinet,et al.  Procoagulant Microparticles: Disrupting the Vascular Homeostasis Equation? , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[8]  Xinjiang Cai Regulation of smooth muscle cells in development and vascular disease: current therapeutic strategies , 2006, Expert review of cardiovascular therapy.

[9]  G. Hansson,et al.  T Cells in Atherogenesis: For Better or For Worse? , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[10]  D. Edelman,et al.  Pericytes and their role in microvasculature homeostasis. , 2006, The Journal of surgical research.

[11]  P. Verhamme,et al.  THE PIVOTAL ROLE OF THE ENDOTHELIUM IN HAEMOSTASIS AND THROMBOSIS , 2006, Acta clinica Belgica.

[12]  V. Fuster,et al.  Links between inflammation and thrombogenicity in atherosclerosis. , 2006, Current molecular medicine.

[13]  B. Webb,et al.  Caldesmon is an integral component of podosomes in smooth muscle cells , 2006, Journal of Cell Science.

[14]  C. Betsholtz,et al.  Pericytes and vascular stability. , 2006, Experimental cell research.

[15]  A. C. van der Wal,et al.  Tissue factor expression in the morphologic spectrum of vulnerable atherosclerotic plaques. , 2006, Seminars in thrombosis and hemostasis.

[16]  E. Bjørklid,et al.  Sources of tissue factor. , 2006, Seminars in thrombosis and hemostasis.

[17]  Steven Song,et al.  The role of pericytes in blood-vessel formation and maintenance. , 2005, Neuro-oncology.

[18]  C. Betsholtz,et al.  Endothelial/Pericyte Interactions , 2005, Circulation research.

[19]  B. Eyden The myofibroblast: a study of normal, reactive and neoplastic tissues, with an emphasis on ultrastructure. Part 1--normal and reactive cells. , 2005, Journal of submicroscopic cytology and pathology.

[20]  Junmei Chen,et al.  Interactions of Platelets with Subendothelium and Endothelium , 2005, Microcirculation.

[21]  H. Hammes,et al.  Pericytes and the Pathogenesis of Diabetic Retinopathy , 2005, Diabetes.

[22]  R. Andriantsitohaina,et al.  Shed membrane microparticles from circulating and vascular cells in regulating vascular function. , 2005, American journal of physiology. Heart and circulatory physiology.

[23]  M. Cilingiroglu,et al.  Vulnerable plaque: Definition, detection, treatment, and future implications , 2005, Current atherosclerosis reports.

[24]  Nitin Kher,et al.  Pathobiology of atherosclerosis--a brief review. , 2004, Seminars in thrombosis and hemostasis.

[25]  D. Paulin,et al.  Desmin: a major intermediate filament protein essential for the structural integrity and function of muscle. , 2004, Experimental cell research.

[26]  I. Charo,et al.  Chemokines in the pathogenesis of vascular disease. , 2004, Circulation research.

[27]  D. Agrawal,et al.  "Vulnerable plaques"--ticking of the time bomb. , 2004, Canadian journal of physiology and pharmacology.

[28]  D. Angiolillo,et al.  Saphenous vein graft disease. , 2004, Minerva cardioangiologica.

[29]  H. Deckmyn,et al.  The hemostatic system. , 2004, Current medicinal chemistry.

[30]  T. Chan-Ling,et al.  Characterization of smooth muscle cell and pericyte differentiation in the rat retina in vivo. , 2004, Investigative ophthalmology & visual science.

[31]  G. Angelini,et al.  Insights into the pathogenesis of vein graft disease: lessons from intravascular ultrasound , 2004, Cardiovascular ultrasound.

[32]  G. Owens,et al.  Molecular regulation of vascular smooth muscle cell differentiation in development and disease. , 2004, Physiological reviews.

[33]  P. Libby,et al.  The vulnerable atherosclerotic plaque: pathogenesis and therapeutic approach. , 2004, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[34]  L. Kritharides,et al.  Cardiac Saphenous Vein Bypass Graft Disease , 2004, Seminars in vascular medicine.

[35]  H. Senoo,et al.  Hepatic sinusoidal cells in liver physiology and pathology , 2004 .

[36]  G. Andò,et al.  A comparison of Power Doppler with conventional sonographic imaging for the evaluation of renal artery stenosis , 2004, Cardiovascular Ultrasound.

[37]  S. Heptinstall,et al.  Transfer of Tissue Factor from Platelets to Monocytes: Role of Platelet-Derived Microvesicles and CD62P , 2002, Thrombosis and Haemostasis.

[38]  J. Shuhaiber,et al.  Mechanisms and future directions for prevention of vein graft failure in coronary bypass surgery. , 2002, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[39]  H. Losken,et al.  Shortening of Mandibular Linear Distance With Multivector Distraction , 2001, The Journal of craniofacial surgery.

[40]  M. Suematsu,et al.  Professor Toshio Ito: a clairvoyant in pericyte biology. , 2001, The Keio journal of medicine.

[41]  P. Helmbold,et al.  Human dermal pericytes express 3G5 ganglioside – A new approach for microvessel histology in the skin , 2001, Journal of cutaneous pathology.

[42]  V. V. van Hinsbergh,et al.  The endothelium: vascular control of haemostasis. , 2001, European journal of obstetrics, gynecology, and reproductive biology.

[43]  R. Gerrity,et al.  Intimal Thickness and Layering, and Smooth Muscle Cell Phenotypes in Aorta of Youth , 2000, Pathobiology.

[44]  A. Newby,et al.  Molecular mechanisms in intimal hyperplasia , 2000, The Journal of pathology.

[45]  E J Topol,et al.  Aortocoronary saphenous vein graft disease: pathogenesis, predisposition, and prevention. , 1998, Circulation.

[46]  E. Andreeva,et al.  Continuous subendothelial network formed by pericyte-like cells in human vascular bed. , 1998, Tissue & cell.

[47]  J. Stockand,et al.  Glomerular mesangial cells: electrophysiology and regulation of contraction. , 1998, Physiological reviews.

[48]  S. Schwartz Smooth muscle migration in atherosclerosis and restenosis. , 1997, The Journal of clinical investigation.

[49]  S. Schwartz Perspectives series: cell adhesion in vascular biology. Smooth muscle migration in atherosclerosis and restenosis. , 1997, The Journal of clinical investigation.

[50]  A. Haeberli,et al.  Anticoagulant Properties of the Vascular Endothelium , 1997, Thrombosis and Haemostasis.

[51]  M J Davies,et al.  Stability and instability: two faces of coronary atherosclerosis. The Paul Dudley White Lecture 1995. , 1996, Circulation.

[52]  A. Zalewski,et al.  Adventitial myofibroblasts contribute to neointimal formation in injured porcine coronary arteries. , 1996, Circulation.

[53]  W J Keon,et al.  Coronary bypass graft fate and patient outcome: angiographic follow-up of 5,065 grafts related to survival and reoperation in 1,388 patients during 25 years. , 1996, Journal of the American College of Cardiology.

[54]  S. Schwartz,et al.  The intima: development and monoclonal responses to injury. , 1995, Atherosclerosis.

[55]  B. Fanburg,et al.  Regulation of endothelial cell xanthine dehydrogenase xanthine oxidase gene expression by oxygen tension. , 1994, The American journal of physiology.

[56]  J. Eyk,et al.  Probing the Regulation of Contractility in Cardiac and Smooth Muscle Skinned Fibers with Synthetic Peptides , 1993 .

[57]  N. Morel,et al.  Pericyte physiology , 1993, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[58]  K. Watson,et al.  Bone morphogenetic protein expression in human atherosclerotic lesions. , 1993, The Journal of clinical investigation.

[59]  M. Bourassa Fate of venous grafts: the past, the present and the future. , 1991, Journal of the American College of Cardiology.

[60]  M. Cybulsky,et al.  Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. , 1991, Science.

[61]  B. Osterud,et al.  Lack of ability to synthesize tissue factor by endothelial cells in intact human saphenous veins. , 1990, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[62]  S. Rapaport,et al.  Localization of human tissue factor antigen by immunostaining with monospecific, polyclonal anti-human tissue factor antibody. , 1990, Thrombosis research.

[63]  Josiahn . Wilcox,et al.  Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[64]  A. Maseri,et al.  Pre-existing coronary stenoses in patients with first myocardial infarction are not necessarily severe. , 1988, European heart journal.

[65]  V. Herzog,et al.  The coronary endothelium: a highly active metabolic barrier for adenosine , 1985, Basic Research in Cardiology.

[66]  R. Mazanet,et al.  Scanning electron microscopy of pericytes in rat red muscle. , 1982, Microvascular research.

[67]  E. Jaffe,et al.  Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. , 1973, The Journal of clinical investigation.

[68]  T. Koyama,et al.  Myocardial capillary net and blood constituents in streptozotocin (STZ)-induced diabetic rats. , 2009, Advances in experimental medicine and biology.

[69]  B. Eyden The myofibroblast: a study of normal, reactive and neoplastic tissues, with an emphasis on ultrastructure. , 2007, Journal of submicroscopic cytology and pathology.

[70]  B. Griffith,et al.  Endothelial injury and acquired aspirin resistance as promoters of regional thrombin formation and early vein graft failure after coronary artery bypass grafting. , 2006, The Journal of thoracic and cardiovascular surgery.

[71]  S. Yamagishi,et al.  Pericyte biology and diseases. , 2005, International journal of tissue reactions.

[72]  A. Santoso,et al.  Identification of pericytes in the central nervous system by silver staining of the basal lamina , 2004, Cell and Tissue Research.

[73]  B. Bouchard,et al.  Human brain pericytes differentially regulate expression of procoagulant enzyme complexes comprising the extrinsic pathway of blood coagulation. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[74]  D. Wellings,et al.  Standard Fmoc protocols. , 1997, Methods in enzymology.

[75]  B. Osterud,et al.  A global view on the role of monocytes and platelets in atherogenesis. , 1997, Thrombosis research.

[76]  Bjarne Østerud,et al.  A global view on the role of monocytes and platelets in atherogenesis. , 1997 .

[77]  U. Moens,et al.  Human polyomavirus BK and immunogenicity of mammalian DNA: a conceptual framework. , 1997, Methods.

[78]  K. Konstantopoulos,et al.  Effects of fluid dynamic forces on vascular cell adhesion. , 1997, The Journal of clinical investigation.

[79]  P. Tracy,et al.  Procoagulant activities expressed by peripheral blood mononuclear cells. , 1993, Methods in enzymology.

[80]  D H Blankenhorn,et al.  A definition of the intima of human arteries and of its atherosclerosis-prone regions. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. , 1992, Circulation.